fingolimod hydrochloride has been researched along with transforming growth factor alpha in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (transforming growth factor alpha) | Trials (transforming growth factor alpha) | Recent Studies (post-2010) (transforming growth factor alpha) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 4,301 | 44 | 623 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Y; Gong, TT; Lei, L; Liang, X; Liu, H; Shan, ZY; Sun, RZ; Wang, Q | 1 |
1 other study(ies) available for fingolimod hydrochloride and transforming growth factor alpha
| Article | Year |
|---|---|
Rapamycin and FTY720 Alleviate Atherosclerosis by Cross Talk of Macrophage Polarization and Autophagy.
Topics: Animals; Arginase; Atherosclerosis; Autophagy; Biomarkers; Cyclooxygenase 2; Fingolimod Hydrochloride; Foam Cells; Interleukin-6; Lipoproteins, LDL; Macrophages, Peritoneal; Membrane Glycoproteins; Mice; Microtubule-Associated Proteins; Nitric Oxide Synthase Type II; Receptors, Lysosphingolipid; Sirolimus; Transforming Growth Factor alpha | 2018 |